GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling

Karlijn L. Kooij, Derek IJsbrand Koster, Emma Eeltink, Mieneke Luijendijk, Lisa Drost, Fabien Ducrocq, Roger A.H. Adan
Neuroscience Applied. 2024-01-01; 3: 103925
DOI: 10.1016/j.nsa.2023.103925

---